Blood Marker and Early Blockage of Heart Bypass Grafts
Studies a heart blood marker and early blockage of bypass grafts in adults.
Plain-language title generated from the registry record
Registry title: Diagnostic and Prognostic Value of Cardiac Biomarkers for Early Coronary Bypass Occlusion in Patients Undergoing Coronary Revascularization
Key facts
- Where
- Wroclaw, PolandSee the site
Where in Poland
- Wroclaw Medical UniversityWroclaw, PolandNot yet recruiting
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- University Hospital, Basel, Switzerland
- Trial code
- NCT04595630
- Record updated
- 25 February 2025
- Original description
This study is to evaluate the correlation between hs-cTn level as cardiac biomarker for ischemia and early graft occlusion as assessed by CCT in patients undergoing coronary bypass surgery.Read full original descriptionShow less
Diagnostic and Prognostic Value of Cardiac Biomarkers for Early Coronary Bypass Occlusion in Patients Undergoing Coronary Revascularization
This study is to evaluate the correlation between hs-cTn level as cardiac biomarker for ischemia and early graft occlusion as assessed by CCT in patients undergoing coronary bypass surgery.
Inclusion: patients with isolated coronary bypass surgery.
Exclusion: Patients requiring a concomitant procedure; Patients that didn't undergo a CCT prior to discharge; Patients with known allergy to iodine-containing contrast agents; Unstable clinical state or severe heart failure; Renal function impairment (serum creatinine >140 mmol/l; estimated glomerular filtration rate (GFR) <30 ml/min/1.73 m2); Patients withholding or lacking informed consent; Exclusion criteria concerning the CCT scan; Pregnancy; Patients with registered MI and registered bypass occlusion in coronary angiogram.